(-)-Epicatechin and β-glucan from highland barley grain modulated glucose metabolism and showed synergistic effect via Akt pathway

In this study, (-)epicatechin (EC) and beta-glucan (BG) were identified as the active compounds in highland barley grain that modulated glucose metabolism. The mechanism underlying EC may target on insulin receptor and regulate target on insulin receptor substrate-1 /phosphatidylinositol 3-kinase / protein kinase B (Akt) pathway, and BG may target on mammalian rapamycin receptor and regulate the Akt pathway. EC and BG showed anti-hyperglycemic effects and modulated hepatic glucose metabolism in mice with impaired glucose tolerance. Moreover, EC combined with BG showed synergistic effects on the Akt pathway, thereby improved glucose uptake through up-regulating glucose transporter 4, improved glycogen synthesis by down-regulating glycogen synthase kinase-3 beta, and inhibiting gluconeogenesis by down-regulating phosphoenolpyruvate carboxykinase 1 protein expression. These results provide evidence of a whole highland barley grain diet to prevent type 2 diabetes or developing EC and BG as new dietary supplement.

Automated summary

The study identified EC and BG in highland barley grain as active compounds that modulate glucose metabolism and have anti-hyperglycemic effects. When combined, they show synergistic effects on the Akt pathway, improving glucose uptake and glycogen synthesis while inhibiting gluconeogenesis. These findings support the use of whole highland barley grain diet for diabetes prevention and potential development of EC and BG as new dietary supplements.